GB1192576A - Diagnostic Substance and Composition - Google Patents

Diagnostic Substance and Composition

Info

Publication number
GB1192576A
GB1192576A GB36091/67A GB3609167A GB1192576A GB 1192576 A GB1192576 A GB 1192576A GB 36091/67 A GB36091/67 A GB 36091/67A GB 3609167 A GB3609167 A GB 3609167A GB 1192576 A GB1192576 A GB 1192576A
Authority
GB
United Kingdom
Prior art keywords
diagnostic substance
composition
diagnostic
aug
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB36091/67A
Inventor
Boris Rajewsky
Gunther Wilhelm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB1192576A publication Critical patent/GB1192576A/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Rehabilitation Therapy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

1,192,576. Diagnostic substance. B. RAJEWSKY and G. WILHELM. 7 Aug., 1967 [6 Aug., 1966 (2)], No. 36091/67. Heading B1X. [Also in Division C3] A diagnostic substance which may be used in immunological tests, for example as a diagnostic for rheumatism comprises a nucleoprotein with a UV maximum of approximately 259 mÁ and a migration velocity of from 4.5. to 6 cm. per 2 hours in electrophoresis (veronal buffer 0.1M., pH 8.6, 11V/cm). It may be obtained from human or animal organs or streptococca.
GB36091/67A 1966-08-06 1967-08-07 Diagnostic Substance and Composition Expired GB1192576A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DER0043854 1966-08-06

Publications (1)

Publication Number Publication Date
GB1192576A true GB1192576A (en) 1970-05-20

Family

ID=7407103

Family Applications (1)

Application Number Title Priority Date Filing Date
GB36091/67A Expired GB1192576A (en) 1966-08-06 1967-08-07 Diagnostic Substance and Composition

Country Status (6)

Country Link
US (1) US3574818A (en)
BE (1) BE702378A (en)
DE (1) DE1617748A1 (en)
GB (1) GB1192576A (en)
NL (1) NL6710785A (en)
SE (1) SE331158B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050042214A1 (en) * 2003-07-15 2005-02-24 Gershwin M. Eric Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis
US20060142561A1 (en) * 2004-12-29 2006-06-29 Mengkui Luo Carboxyalkyl cellulose
US7241836B2 (en) * 2004-12-29 2007-07-10 Weyerhaeuser Co. Method of crosslinking a mixture of carboxylated polymers using a triazine crosslinking activator
US7393905B2 (en) * 2004-12-29 2008-07-01 Weyerhaeuser Company Crosslinked mixed carboxylated polymer network
US7230049B2 (en) * 2004-12-29 2007-06-12 Weyerhaeuser Co. Method of crosslinking a carboxylated polymer using a triazine crosslinking activator
US7300965B2 (en) * 2004-12-29 2007-11-27 Weyerhaeuser Company Mixed polymer network
US7541396B2 (en) * 2004-12-29 2009-06-02 Weyerhaeuser Nr Company Method for making carboxyalkyl cellulose
US20060142478A1 (en) * 2004-12-29 2006-06-29 Mengkui Luo Carboxyalkyl cellulose polymer network
US20060142476A1 (en) * 2004-12-29 2006-06-29 Weerawarna S A Crosslinked carboxylated polymer
US20060143473A1 (en) * 2004-12-29 2006-06-29 Kumar Mohan J Software key implementation using system management firmware
US20060142481A1 (en) * 2004-12-29 2006-06-29 Herriott Carole W Method for making a mixed polymer network
US7183638B2 (en) 2004-12-30 2007-02-27 Intel Corporation Embedded heat spreader

Also Published As

Publication number Publication date
DE1617748A1 (en) 1971-04-08
SE331158B (en) 1970-12-14
NL6710785A (en) 1968-02-07
BE702378A (en) 1968-02-07
US3574818A (en) 1971-04-13

Similar Documents

Publication Publication Date Title
GB1531762A (en) Cancer antigen cancer therapy and cancer diagnosis
GB1192576A (en) Diagnostic Substance and Composition
ES8307744A1 (en) Salts of N-substituted-2-pyrrolidone-4-carboxylic acids as humectants.
IT1075449B (en) STABILIZED ENZYMATIC CONCENTRATE OF GLUCOSE-ISOMERASE AND PROCEDURE TO PREPARE IT
FR1923M (en) Amino acid concentrate and compositions containing this concentrate.
IT1036121B (en) PROCEDURE FOR THE PREPARATION OF NUTRITIONAL COMPOSITIONS FOR ANIMAL FEEDING
GR36834B (en) METHOD AND COMPOSITIONS FOR THE INTRODUCTION OF ALCOXYVENZAMIDE IN THE CIRCULATORY SYSTEM.
CH445021A (en) Process for the manufacture of therapeutically active preparations with long lasting effects for oral administration
SE7504587L (en) PROSTANIC ACID DERIVATIVES AND METHOD OF THEIR PREPARATION.
FR1495559A (en) Polyurethane, method of preparation and resulting adhesive compositions
ES411617A1 (en) Cyanophenyl esters of oxime-o-carbonic acid
GB1357564A (en) Glycoproteins
BE586329A (en) Improvements to Methods and Compositions for Stimulating Animal Growth
ES294348A1 (en) Procedure for preparing new products for skin care (Machine-translation by Google Translate, not legally binding)
IT1053253B (en) METHOD FOR THE PREPARATION OF AN ACTIVE AVIROLENT VACCINE TO COMBAT ABORTION IN THE CATTLE AND RELATED PRODUCT
GR35650B (en) DETERGENT COMPOSITION.
BE778754A (en) PREPARATION OF ANTIGEN EXTRACTS OF ANIMAL THYMOCYTES, SERUMS AND ANTITHYMOCYTARY DEGAMMA-GLOBULINS SPECIFIC TO AN ANIMAL SPECIES AND THEIR THERAPEUTIC APPLICATIONS
IT997922B (en) METHOD AND COMPOSITION TO STIMULATE THE GROWTH OF PLANTS
GR34158B (en) METHOD OF PREPARATION OF BIOLOGICALLY ACTIVE AMIDES.
CH400453A (en) Procedure for the formation of artificial teeth
IT1048304B (en) IMPROVEMENT IN DIAGNOSTIC SYSTEMS OF MICROBIAL DISEASES IN PARTICULAR TO DETERMINE THE QUANTITY OF ANTIBODIES PRODUCED
ATE18234T1 (en) PROCESS FOR THE PREPARATION OF 3-ALPHA,7-BETADIHYDROXY-5-BETA-CHOLANIC ACID.
CA806152A (en) Method of dyeing animal fibers
FR1336363A (en) Methods of preparing baker's yeast, yeast obtained and application
FR1295348A (en) Improvements in Methods and Compositions for Stimulating Animal Growth

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PLNP Patent lapsed through nonpayment of renewal fees